P. A. Bunn

1.9k citations

39 papers · 1.6k indexed · 1 hit paper · h-index 14

Impact in

Oncology top 5%
- Lung Cancer Research Studies
Virology top 5%
- HIV Research and Treatment

Papers in

Oncology 23
- Lung Cancer Research Studies 12
- Colorectal Cancer Treatments and Studies 5
- Peptidase Inhibition and Analysis 4
Pulmonary and Respiratory Medicine 21
- Lung Cancer Treatments and Mutations 18
- Gastric Cancer Management and Outcomes 6
- Lung Cancer Diagnosis and Treatment 4

Co-authors: GP Schechter AF Gazdar ES Jaffe John D. Minna Martin H. Cohen Robert Makuch Adi F. Gazdar John G. Guccion
Journals: Journal of Clinical Oncology (13 papers)Lung Cancer (6 papers)Blood (5 papers)Annals of Oncology (3 papers)Journal of Thoracic Oncology (2 papers)
Partner nations: United States Denmark United Kingdom

In The Last Decade

P. A. Bunn

38 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas 1980 · 387 citations

Peers

Countries citing papers authored by P. A. Bunn

Since Specialization

Citations

This map shows the geographic impact of P. A. Bunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. A. Bunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. A. Bunn more than expected).

Fields of papers citing papers by P. A. Bunn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. A. Bunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. A. Bunn. The network helps show where P. A. Bunn may publish in the future.

Co-authors

The 25 scholars most cited alongside P. A. Bunn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P. A. Bunn Line = papers co-authored together P. A. Bunn links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	FP10.04 RESILIENT Part 1: Safety and Efficacy of Second-Line Liposomal Irinotecan in Patients with Small Cell Lung Cancer Journal of Thoracic Oncology ·Luis Paz‐Ares, David R. Spigel, Yuanbin Chen, Maria Jové, Óscar Juan, Patricia Rich, Theresa Hayes, Catherine Pitman, Beth Trask, Alejandro Navarro, Afshin Dowlati, Bin Zhang, Yan Moore, Корякина Анжелина Анатольевна, T. Boukour, Santiago Ponce, P. A. Bunn	2021	1
2	Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: The NCI’s Lung Cancer Mutation Consortium (LCMC). Journal of Clinical Oncology ·Mark G. Kris, B. E. Johnson, D J Kwiatkowski, A. John Iafrate, Ignacio I. Wistuba, Samuel L. Aronson, J. A. Engelman, Yu Shyr, Fadlo R. Khuri, Charles M. Rudin, Edward B. Garon, William Pao, Joan H. Schiller, Eric B. Haura, 加藤晴康, Giuseppe Giaccone, Lynne D. Berry, Kelly Kugler, John D. Minna, P. A. Bunn	2011	176
3	Meta-analysis of the predictive and prognostic value of erlotinib-related biomarkers in phase III, placebo-controlled trials in non-small cell lung cancer (NSCLC): Recommendations of the BioLOGUE advisors. Journal of Clinical Oncology ·M M Stewart, Jürgen Wolf, Frances A. Shepherd, Federico Cappuzzo, P. A. Bunn, Roy S. Herbst, F. R. Hirsch, Keith M. Kerr, Tetsuya Mitsudomi, Ming‐Sound Tsao, Huili YANG, Frank C. Richardson, Barbara Klughammer, Bret Wacker, David Sternberg, Angela M. Davies	2011	8
4	Synergistic effect of SNDX-275 with lapatinib or erlotinib in breast, lung, or head and neck cancer cell lines expressing HER- 2 Journal of Clinical Oncology ·Samir E. Witta, Hochstraße Die, Kimihide Yoshida, Richard Schebler, Barbara Frederick, Marileila Varella‐Garcia, P. A. Bunn, F. R. Hirsch	2009	1
5	The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer Annals of Oncology ·Glen J. Weiss, Rafael Rosell, Frank V. Fossella, Michael C. Perry, Rolf A. Stahel, Fernando Barata, Binh Nguyen, S. Paul, D.M. Moore, Nasser H. Hanna, Karen Kelly, P. A. Bunn	2007	65
6	Epidermal growth factor receptor (EGFR) immunohistochemistry: Comparison of antibodies (Abs) and cut points to predict benefit from gefitinib in a phase III placebo-controlled study in advanced non-small cell lung cancer (NSCLC) Journal of Clinical Oncology ·Rafał Dziadziuszko, Fred R. Hirsch, Marileila Varella‐Garcia, N. Thatcher, Helen Mann, Claire Watkins, Georgina Speake, B. R. Holloway, P. A. Bunn, W. Franklin	2007	4
7	Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy Annals of Oncology ·Rafał Dziadziuszko, Bente Holm, J.C. Delgado, Kell Østerlind, Nanda Hidayati, W. Franklin, P. A. Bunn, Marileila Varella‐Garcia, F. R. Hirsch	2006	37
8	Prognostic significance of EGFR FISH and IHC in non small-cell lung cancer patients treated with chemotherapy alone Journal of Clinical Oncology ·Rafał Dziadziuszko, Bente Holm, J.C. Delgado, Kell Østerlind, Wilbur A. Franklin, M. Varella-Garcia, P. A. Bunn, F. R. Hirsch	2006	1
9	Studies of pemetrexed and gemcitabine, alone and in combinations, in human lung cancer models Journal of Clinical Oncology ·Dan Chan, Ajit Shrestha, Philip Rankin, B. Helfrich, F. R. Hirsch, Di Ma, P. A. Bunn	2006	4
10	Evaluation of HER2/neu expression in lung tumors by immunohistochemistry and fluorescence in situ hybridization (FISH) Lung Cancer ·Fred R. Hirsch, Robert Veve, Francisco Perez Flores, P. A. Bunn, Wilbur A. Franklin	2000	9
11	Fifth I.A.S.L.C. Lung Tumor Biology Workshop, August 13–17, 1996, Ermatingen, Switzerland Annals of Oncology ·P. A. Bunn, Xiaonan Xu, A. Samavedam, Cynthia K. Harris, K. Havemann, M Mabry, Marko Radetić, Nagahiro Saijo, Hans Skovgaard Poulsen, R. Stahel, Takashi Takahashi, P R Twentyman	1997	1
12	Anti-growth factor therapy for lung cancer Lung Cancer ·P. A. Bunn, David Chan, Dan Weijun, Lynn E. Heasley, Julie Stewart, Lajos Gera, Ayussy Rahma Aulia, B. Helfrich	1997	2
13	Automated fluorescent analysis for drug-induced cytotoxicity assays. PubMed ·Nina S. Funa, Nancy A. Dawson, M. Tonnier, Hans Ågren, John C. Ruckdeschel, P. A. Bunn, Adi F. Gazdar	1986	7
14	A COMPARISON OF COMPUTED TOMOGRAPHY AND RADIONUCLIDE SCANNING FOR DETECTION OF BRAIN METASTASES IN SMALL CELL LUNG CANCER Journal of Computer Assisted Tomography ·Allwell Iye Agada-Adeleye, Stefan Borg, D C Ihde, Robert Makuch, Eli Glatstein, LI Su-lin, Anita Johnston-Early, Hampton R. Bates, Neeraj Saini, Martin H. Cohen, P. A. Bunn	1985	2
15	Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemia Blood ·KA Foon, RW Schroff, P. A. Bunn, 覃鸿杰, Javier Verde, K. Livingston, Kaori Yotsuya, Lou Pingeot, L.G.S. Mota, Qinmin Ma	1984	2
16	Role of radiation therapy in small cell anaplastic carcinoma of the lung. PubMed ·N M Bleehen, P. A. Bunn, James D. Cox, P Dombernowsky, R. M. Fox, Jung Ah Young, R Joss, John White, R. Wittes	1983	81
17	Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas Blood ·AF Gazdar, Amandine Ramond, P. A. Bunn, Arif Bintoro, ES Jaffe, GP Schechter, Kritik Meiner	1980	279
18	Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas Blood ·AF Gazdar, Amandine Ramond, P. A. Bunn, Arif Bintoro, ES Jaffe, GP Schechter, Kritik Meiner Hit paper breakdown →	1980	387
19	Bone marrow metastases in small cell carcinoma of the lung: frequency, description, and influence on chemotherapeutic toxicity and prognosis Blood ·DC Ihde, Brian J. Nuessler, MJ Matthews, Daria D. Mikheeva, P. A. Bunn, Mahuizotl Mendoza Guerrero	1979	40
20	5-fluorouracil, methyl-CCNU, adriamycin, and mitomycin C in the treatment of advanced gastric cancer. PubMed ·P. A. Bunn, Mamusha Lemma Ato, Daniel C. Ihde, Martin H. Cohen, Joyce L. Eddy, John D. Minna	1978	10

About P. A. Bunn

P. A. Bunn is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Epidemiology and Dermatology, having authored 39 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (12 papers), Neuroendocrine Tumor Research Advances (8 papers), Gastric Cancer Management and Outcomes (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Radiomics and Machine Learning in Medical Imaging (4 papers), Peptidase Inhibition and Analysis (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Oncology (837 citations), Virology (125 citations), Immunology (486 citations), Agronomy and Crop Science (205 citations) and Pulmonary and Respiratory Medicine (548 citations). P. A. Bunn has collaborated with scholars based in United States, Denmark and United Kingdom. Frequent co-authors include GP Schechter, AF Gazdar, ES Jaffe, John D. Minna, Martin H. Cohen, Robert Makuch, Adi F. Gazdar, John G. Guccion, D N Carney and Allen S. Lichter. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Blood, Annals of Oncology and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact